Clinical and laboratory profile of patients with amoebic liver abscess

Amebic liver abscess (ALA) occurs in 3%-9% of the amebiasis cases, with complications seen in 20%-40% of the cases and 2%-18% mortality rate. Successful treatment thus requires the accurate identification of these cases. We aimed to assess the seropositivity and profile of ALA patients in western Rajasthan. This retrospective study was conducted at a tertiary care center in western Rajasthan from November 2017 to May 2019. Serological diagnosis of ALA was done by detecting immunoglobulin G (IgG) antibodies in the serum of the patients by ELISA. The derangements in laboratory profile (hematological and biochemical parameters) and ultrasonography findings were assessed from the hospital records. Statistical analysis was performed using Mann-Whitney U-test. Among the total cases ( = 34), 20 were diagnosed as ALA. Twenty-one (61.8%) were positive for anti-amebic IgG antibodies. Among ALA patients, 14 (70%) were >40 years old and only 6 (30%) patients were of age ≤40 years. Male: female ratio was 5.7:1, and ultrasonography records of 15 ALA patients revealed the presence of hepatomegaly ( = 7, 46.7%), pleural effusion ( = 3, 20%), lung collapse ( = 2, 13.3%), and vascular involvement ( = 1, 6.7%). The right lobe of the liver was involved in majority of the patients ( = 12, 80%). Total white blood cell count ( < 0.001), absolute neutrophil count ( = 0.001), total serum bilirubin ( = 0.019), and serum alkaline phosphatase ( = 0.018) were significantly elevated in ALA patients. Seroprevalence shows that ALA still remains the dominant etiology in liver abscess patients in this region. There are significant derangements in the laboratory profile that require a larger study for corroboration.